Some patients with low-risk acute granulocytic leukemia type m2 are potentially curable, but most are unlikely to be cured. 1. Acute granulocytic leukemia type m2 is a type of acute granulocytic leukemia. The main symptoms are obvious hyperplasia of the granulocyte lineage, Auer vesicles can be seen; the erythroid lineage and megakaryocyte lineage have suppressed hyperplasia and other symptoms. According to the different degree of granulocyte differentiation is divided into the following two types: (1) M2a type, with 30% to 90% of progranulocytes, monocytes <20%, and the following stages of premature granulocytes >10%. (2) M2b type, there is a significant increase in the number of primitive and early juvenile granulocytes, but the proliferation of abnormal neutrophilic neutrophils is predominant, their nuclei often have nucleoli, and there is a significant imbalance in the development of the nucleus and pulp, and this type of cells>30%. 2. Some low-risk patients with acute granulocytic leukemia type m2 may be able to achieve clinical cure through chemotherapy alone, but the cure rate is low. Most of the patients, especially the middle and high-risk ones, need to be treated with chemotherapy and allogeneic hematopoietic stem cell transplantation to have the possibility of cure. However, under the premise of successful matching, allogeneic hematopoietic stem cell transplantation should also take into account the severity of the rejection reaction after transplantation, and the severe rejection reaction may endanger the patient’s life. Patients suffering from this disease should go to regular hospitals to receive professional diagnosis and treatment as soon as possible to avoid delays.